induction of IL-2 mRNA and IL-2 production after syngeneic BMT (sBMT) showed early restoration of this cytokine, implying a relative minor role of endogenous IL-2 in Lethally irradiated BALB/c mice were reconstituted by syngeneic bone marrow transplantation (BMT), and the pathogenesis of post-BMT immune deficient state.
Interleukin 7 (IL-7), a 25 kDa glycoprotein isolated from injected with recombinant interleukin 7 (rIL-7), recombinant interleukin 2 (rIL-2), or saline 10 days postthe murine bone marrow stromal cell line, has been described as a growth promoting, and possibly differentransplantation. Intranasal infection with A/PR8/34 influenza virus 2 weeks after BMT was associated with tiating, factor of pre-B cells and immature thymocytes.
8-10
Endogenous IL-7 has also been found to be involved in the the highest survival rate in the rIL-7-treated group. The protective mechanism elicited by rIL-7, as manifested development of cytotoxic T lymphocytes (CTL), as evidenced by complete blocking of its activity by anti IL-7 by very low virus titers in the lung, involves T and B cell functions. High hemagglutinin inhibition antibody serum. 11 The cytokine has further been shown to promote V(D)J gene rearrangement in the precursor T cells. 12 In an levels were observed on days 7 and 12 post-challenge in the rIL-7 mice. Moreover, the anti-influenza cytotoxic earlier investigation, we probed the ability of IL-7 to induce rearrangement of the V␤8 T cell receptor gene after sBMT T lymphocyte activity was induced primarily by rIL-7, leaving the effect of rIL-2 on the same level as that of in mice; 13 it appeared that rIL-7 is directly involved in signal transduction of both V(D)J and RAG-1 gene expression. the control. Thus, rIL-7 promotes both T cell-mediated function and B cell production during the immunoBolotin et al 14 very recently found, in line with our results, that administration of IL-7 after BMT enhanced thymodeficient state after BMT. This cytokine may prove a potential immunotherapeutic modality in BMT poiesis, even when donor bone marrow was depleted of mature T lymphocytes. recipients. Keywords: bone marrow transplantation; interleukin 7;
The present murine study investigates the effect of rIL-7-induced gene rearrangement on immune function in the T lymphocytes context of viral infection after sBMT in mice. The experiments were drafted so as to follow the kinetics of the specific immune response against influenza virus at the level Autologous bone marrow transplantation (BMT) is being of antibody production, as well as to detect generation of used with increasing frequency to permit administration of cytotoxic T lymphocytes. otherwise lethal doses of irradiation, chemical agents or various combinations of both, in an attempt to eradicate Materials and methods tumor cells in patients with malignancies.
1,2 Numerous studies have shown the addition of myeloid growth factors All animal procedures utilized in this study were approved to the treatment regimen after autologous BMT to hasten by the Institutional Committee for Animal Experimenthe time to durable engraftment of hematopoietic cells. 3 In tation. contrast to the recovery of the myeloid cells, the reconstitution of lymphocyte function is delayed, making it the causative mechanism for the prolonged immune deficiency Mice state post-BMT, both with regard to protection from infecFemale BALB/c mice, aged 10-16 weeks, were obtained tion and immune-mediated anti-tumor activity. Arlington Heights, IL, USA) for 90 min at 37°C as previously described. 16 Four concentrations of CTL (effectorBone marrow transplantation to-target ratios of 30:1, 10:1, 3:1 and 1:1) were added in The donor mice were killed by cervical dislocation; the triplicate to 10 4 influenza-infected target cells in 96-well long bones (femora, tibiae and humeri) were removed and U-shaped bottom plates in RPMI 1640 with 10% FCS. The the marrow cavities were flushed with RPMI 1640 medium plates were centrifuged and incubated for 6 h at 37°C. An (Biolab, Jerusalem, Israel) using a 25-gauge needle. Cell aliquot (100 l) of supernatant was then removed from suspensions were filtered through a fine nylon mesh and each well, and 51 Cr release was determined in a gamma washed twice in RPMI medium. Aliquots (0.3 ml medium counter. Spontaneous and maximal release were determined containing 10 7 nucleated cells) were injected intravenously by incubating 51
Cr-labeled A/PR/8 influenza virus infected into the lateral tail vein of recipient mice 24 h post-P 815 cells with either 100 l media or 100 l of Triton Xirradiation.
100 (Fisher Scientific, Pittsburgh, PA, USA). The percentage of specific chromium release was calculated by subtracting spontaneous released counts per minute from Administration of rIL-2 and rIL-7 in vivo release in the presence of CTL divided by the maximal All mice were subjected to total body irradiation and subreleased counts per minute minus the spontaneous release. sequent sBMT, after which they were divided into three This fraction was multiplied by 100. groups (15 animals/group). One group was injected intraperitoneally with rIL-7 (100 ng × 2/day for 10 days), the Serum hemagglutination inhibition antibody titration second group received intraperitoneal rIL-2 (1000 units × 2/day for 10 days), and the third group was given Individual blood samples were collected by bleeding from saline (control). A fourth group of non-transplanted mice the retro-orbital sinuses and sera were treated with vibrio served as untreated (normal) animals. Each experiment was cholera receptor destroying enzyme (Sigma, St Louis, MO, repeated three times. Human rIL-2 was kindly provided by USA) for 18 h at 37°C, followed by heat inactivation for Eurocetus/Chiron BV (Amsterdam, The Netherlands) as 30 min at 56°C. HI antibody titers were determined by 1 mg proleukin (18 × 10 6 international units is equivalent microtitration using four hemagglutination units. to 3 × 10 6 cetus units) and human rIL-7 was a gift from Peprotech (Princeton, NJ, USA) in the form of lyophilized Protection powder soluble in water. The cytokine was reconstituted in phosphate buffered saline (PBS) to a concentration of
The susceptibility of each experimental group to influenza 100 ng/ml. infection was tested by an intranasal challenge with 50 l PBS containing the lethal dose of 10 6 50%/EID 50 units, Challenge with influenza virus administered under light anesthesia 2 weeks after immunization. Seven and 12 days following challenge, mice were Susceptibility of the sBMT recipients and non-transplanted killed and their lungs removed, frozen in PBS containing (normal) mice to influenza virus infection was tested by 0.1% gelatin and stored at −70°C. To detect viable virus in intranasal administration of the live influenza A/PR/8/34 lungs, 2 × 10 4 MDCK cells were seeded into each well of H1N1 virus 2 weeks after BMT. Each mouse received a 96-well tissue culture microplate and incubated overnight 50 l PBS containing 10 6 50%/EID 50 under light anesat 37°C. A/PR/8 influenza virus-infected allantoic fluid and thesia. Survial was monitored daily during the experithe lung sample suspensions were serially diluted in 10-mental period.
fold steps from 10 −1 to 10 −9 in DMEM containing 1% bovine serum albumin, 0.01% sodium bicarbonate, and 0.1%
Cytotoxic T lymphocyte (CTL) cultures in vitro
gentamicin. A 25-l aliquot of an appropriate dilution of each dilution was added to MDCK cells in triplicate wells Single-cell preparations from pooled spleens from mice of tissue culture plates. After 1 h incubation at 37°C, 175 l (three mice/group) immunized 2 weeks previously with the DMEM with bovine serum albumin, sodium bicarbonate, influenza virus or recombinant vaccinia virus were culgentamicin and 2 g/ml trypsin (Sigma type IX from portured. 15 Briefly, 15 × 10 6 spleen cells were mixed with cine pancreas, crystallized, dialyzed, lyophilized) was 5 × 10 6 syngeneic, irradiated (2000 rad) A/PR/8 influenza added to each well. Forty-eight hours later, the virus titers virus-infected feeder spleen cells in 10 ml complete were established by determining the hemagglutination titers medium (RPMI 1640, 10% FCS, 5 × 10 −5 m 2-mercaptoof supernatants from each individual well. The TCID 50 was ethanol, penicillin and streptomycin). The cultures were calculated using the Reed and Muench method 17 and given harvested after 7 days incubation at 37°C and assayed for in log 10 units. 51 Cr release. The responding CTL were harvested and tested for their activity.
Statistical evaluation 51 Cr release cytotoxicity assay
The independent t test was used for comparison between the groups. Differences at the P Ͻ 0.05 level were conFor this assay P 815 cells were used as targets. The cells were washed twice with serum-free medium (RPMI 1640), sidered significant.
Results

Effect of rIL-2 and rIL-7 on influenza viral replication in the lung of post-sBMT mice
Lungs were harvested 7 and 12 days post-viral inoculation, homogenized, serially diluted and seeded on MDCK cells. The log 10 tissue culture infectious dose of the influenza titers was used to express the rate of viral replication in the lungs in mice that underwent BMT and treated by either saline or each of the cytokines. As seen in Table 1 , 7 days after inoculation, the rate of viral replication was highest among the controls, followed by IL-2-treated mice, the IL-7-treated group showing the lowest viral titers. Complete clearance of the influenza virus from the lungs of the IL-7 treated mice was observed by day 12, while the control and IL-2 group still showed a heavy load of the virus (differences between IL-7 vs IL-2 and saline groups were statistically significant, P Ͻ 0.05 for both days tested). In parallel, survival was monitored within each of the experimental group. Within 2 weeks of influenza challenge, Ͼ90% of the rIL2 and saline-treated mice succumbed; in the rIL-7 group Ͼ40% survived for more than 20 days (P = 0.0035) (data not shown). The dosages of the two cytokines used in this study did not lead to toxic death in the virus-free controls. Effect of rIL-2 and rIL-7 on CTL activity level postsBMT CTL activity against the influenza virus, especially at an effector-to-target ratio of 30:1 (Figure 1b) . The transplanted To assay specific cytotoxicity against the influenza virus, saline group (control) showed enhanced cytotoxic activity CTL activity was measured in splenic cells 12 days after superseding that of the non-transplanted-virus challenged viral inoculation. The IL-7-treated mice showed the highest (normal) mice (Figure 1b) . This phenomenon was also reflected in the level of viral infection in the lungs (Table 1 ). This effect is probably due to the known post-BMT are largely obscure. In the present murine study,
Effect of rIL-2 and rIL-7 on hemagglutination inhibition
The values refer to individual mice.
IL-7 treatment post-sBMT induced a specific immune response, providing protection from influenza virus infecreflects a lack of IL-7 production after BMT, a factor that can only be established once accurate appropriate assays tion by increasing both antibody production and cytotoxic cellular activity.
become available. In a mouse model of fibrosarcoma, IL-7 surpassed IL-2 IL-7 is a potent stimulus in generating proliferative signals to B and T cell precursors and, to a lesser extent, in and IL-4 in generating CTL activity against the tumor, 31, 32 findings that inspired us to examine specific cell cytotoxicactivating mature T cells. [19] [20] [21] In fact, IL-7-deficient mice have demonstrated profound inhibition of lymphoid develity against viral infection. The CTL activity against the influenza virus was primarily IL-7-induced, leaving the opment, in contrast to gene inactivation of other cytokines. 22 It has been suggested that the lymphokine acts via effect of IL-2 on the same plane as that of the saline in the controls. Considering that, unlike IL-2, IL-7 is a growth mechanism(s) enabling it to support the rearrangement of the T cell receptor ␤ gene in cultured thymocytes. 12 In a factor for the earliest lymphoid cells, 22 its mechanism of action in the protection from viral infection might be primprevious study rIL-7 immunotherapy was shown to induce early transcription of the RAG-1 gene, and consequent arily CD8-mediated. It should be taken into account, however, that in the murine complex each of the cytokines may accelerated V␤8 gene rearrangement. 13 In the present investigation, we used an in vivo approach to pinpoint the fundaelicit CTL activity from different cell populations.
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As far as we could ascertain, the present study is the first mental role of T cell receptor gene rearrangement within the realm of IL-7 activity inducing protection from viral to show that in vivo administered rIL-7 boosts specific T cell differentiation and improves B cell function postinfection after BMT. The cytokine boosted survival after challenge with influenza virus post-sBMT.
sBMT. Although clinical trials with rIL-7 in BMT patients are still awaited, and its effects on the basic malignant disWith regard to IL-2, there is accumulating data that immunotherapy with this cytokine may decrease the danger ease, 33 GVHD, rejection and, especially, induction of GVL via non-specific NK cells remain to be established, the curof relapse of hematologic malignancies.
23, 24 It has been postulated that IL-2 might induce, or augment, the graftrent data suggest a potential role of this cytokine as an immunotherapeutic modality early after BMT. versus-leukemia (GVL) reaction via its effect on T and non-T lymphocytes. 25, 26 In animals, IL-2 has been shown to induce a GVL effect; however, it may also either exacerbate or protect against graft-versus-host disease (GVHD)enon of the relatively low CTL activity mounted by the leukemia reactions after bone marrow transplantation. Blood normal mice has been reported before. 15 The augmentation In the light of these findings it is justifiable to assume comparison to infection after allogeneic bone marrow transthat IL-7 activity was targeted at more than one cell type, 
